Form 4 for SER Serina Therapeutics, Inc.
Accepted 2024-06-27 00:00:00 ET · period of report 2024-06-21 · accession 0001493152-24-025498 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-06-27 | 2024-06-21+ | SER | MINTZ STEVEN | Dir | P - Purchase | $9.33 | +7,600 | 10.9K | +230% | +$70.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-21 | P | A | 5,000 | $9.50 | 8,307 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-25 | P | A | 2,600 | $9.00 | 10,907 | D | — | — |